Cargando…

Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?

Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarashi, Samira, Siadat, Seyed Davar, Ahmadi Badi, Sara, Zali, Mohammadreza, Biassoni, Roberto, Ponzoni, Mirco, Moshiri, Arfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920974/
https://www.ncbi.nlm.nih.gov/pubmed/31766208
http://dx.doi.org/10.3390/microorganisms7110561
_version_ 1783481056638271488
author Tarashi, Samira
Siadat, Seyed Davar
Ahmadi Badi, Sara
Zali, Mohammadreza
Biassoni, Roberto
Ponzoni, Mirco
Moshiri, Arfa
author_facet Tarashi, Samira
Siadat, Seyed Davar
Ahmadi Badi, Sara
Zali, Mohammadreza
Biassoni, Roberto
Ponzoni, Mirco
Moshiri, Arfa
author_sort Tarashi, Samira
collection PubMed
description Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of the normal community of gut bacteria is an important issue in the development of CRC. However, several studies have already evaluated the different aspects of the association between microbiota and CRC. The current study aimed at reviewing and summarizing most of the studies on the modifications of gut bacteria detected in stool and tissue samples of CRC cases. In addition, the importance of metabolites derived from gut bacteria, their relationship with the microbiota, and epigenetic modifications have been evaluated.
format Online
Article
Text
id pubmed-6920974
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69209742019-12-24 Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? Tarashi, Samira Siadat, Seyed Davar Ahmadi Badi, Sara Zali, Mohammadreza Biassoni, Roberto Ponzoni, Mirco Moshiri, Arfa Microorganisms Review Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of the normal community of gut bacteria is an important issue in the development of CRC. However, several studies have already evaluated the different aspects of the association between microbiota and CRC. The current study aimed at reviewing and summarizing most of the studies on the modifications of gut bacteria detected in stool and tissue samples of CRC cases. In addition, the importance of metabolites derived from gut bacteria, their relationship with the microbiota, and epigenetic modifications have been evaluated. MDPI 2019-11-13 /pmc/articles/PMC6920974/ /pubmed/31766208 http://dx.doi.org/10.3390/microorganisms7110561 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tarashi, Samira
Siadat, Seyed Davar
Ahmadi Badi, Sara
Zali, Mohammadreza
Biassoni, Roberto
Ponzoni, Mirco
Moshiri, Arfa
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title_full Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title_fullStr Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title_full_unstemmed Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title_short Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
title_sort gut bacteria and their metabolites: which one is the defendant for colorectal cancer?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920974/
https://www.ncbi.nlm.nih.gov/pubmed/31766208
http://dx.doi.org/10.3390/microorganisms7110561
work_keys_str_mv AT tarashisamira gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT siadatseyeddavar gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT ahmadibadisara gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT zalimohammadreza gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT biassoniroberto gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT ponzonimirco gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer
AT moshiriarfa gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer